Omega Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 13, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	1	166	274	541	-	-
Market Cap Growth	-43.24%	-39.50%	-49.31%	-	-	-
Enterprise Value	99	208	149	319	-	-
Last Close Price	0.02	3.01	5.71	11.33	-	-
PS Ratio	0.11	53.64	132.35	3758.96	-	-
PB Ratio	0.08	2.86	2.59	2.70	-	-
P/TBV Ratio	5.83	2.86	2.59	2.70	-	-
EV/Sales Ratio	12.19	67.19	71.83	2215.28	-	-
Debt / Equity Ratio	11.10	2.21	0.21	0.10	1.11	-1.29
Asset Turnover	0.04	0.02	0.01	0.00	-	-
Quick Ratio	1.30	3.00	5.76	18.85	3.01	1.02
Current Ratio	1.61	3.35	6.26	19.13	3.12	1.19
Return on Equity (ROE)	-166.90%	-118.82%	-66.99%	-64.65%	-4249.21%	-
Return on Assets (ROA)	-25.01%	-35.77%	-33.86%	-31.57%	-104.69%	-
Return on Capital (ROIC)	-26.72%	-39.79%	-36.80%	-33.99%	-143.17%	-
Earnings Yield	-8250.97%	-58.70%	-37.43%	-12.61%	-	-
FCF Yield	-6506.68%	-56.86%	-36.41%	-10.91%	-	-
Buyback Yield / Dilution	-5.61%	-12.80%	-113.71%	-473.56%	-17.69%	-
Total Shareholder Return	-5.61%	-12.80%	-113.71%	-473.56%	-17.69%	-

Source: S&P Capital IQ. Standard template. Financial Sources.